Comparative Pharmacology
Head-to-head clinical analysis: FLAC versus HYDROCORTISONE ACETATE 1 AND PRAMOXINE HYDROCHLORIDE 1.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLAC versus HYDROCORTISONE ACETATE 1 AND PRAMOXINE HYDROCHLORIDE 1.
FLAC vs HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FLAC (Fluorouracil) is a pyrimidine analog that inhibits thymidylate synthase, blocking DNA synthesis. It is converted to active metabolites (FdUMP, FUTP) that disrupt RNA function and DNA replication.
Hydrocortisone acetate is a corticosteroid that binds to glucocorticoid receptors, modulating gene expression to reduce inflammation, vasodilation, and immune cell activity. Pramoxine hydrochloride is a local anesthetic that reversibly blocks sodium ion channels in nerve cell membranes, inhibiting nerve impulse conduction and providing topical anesthesia.
Adults: 40 mg orally twice daily.
Apply a thin film to affected area three to four times daily. Topical only.
None Documented
None Documented
2-4 hours; prolonged in renal impairment (up to 12 hours)
Hydrocortisone acetate: 1.5–2 hours (plasma), clinically adrenocortical suppression lasts 24–48 hours; pramoxine: not applicable due to minimal absorption.
Renal: 70% unchanged; Fecal: 20%; Biliary: 10%
Hydrocortisone acetate: primarily renal (about 90% as metabolites, less than 1% unchanged); pramoxine HCl: negligible systemic absorption, eliminated primarily via fecal excretion.
Category C
Category D/X
Corticosteroid
Corticosteroid